Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × alectinib × Thoracic × Clear all

Phase

Status

Sponsor Class

INDUSTRY 19 OTHER 13 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 36 Carboplatin 35 Radiotherapy 28 Paclitaxel 28 Pemetrexed 15 Gemcitabine 15 Etoposide 15 Docetaxel 15 Bevacizumab 10 Radiosurgery 9 Magnetic Resonance Spectroscopy 8 durvalumab 7 Taxes 6 Cetuximab 6 pembrolizumab 5 Specimen Handling 5 Ramucirumab 5 Irinotecan 5 Gene Expression Profiling 5 Filgrastim 5 Erlotinib Hydrochloride 5 Vinorelbine 4 Polymerase Chain Reaction 4 Neoadjuvant Therapy 4 Chemotherapy, Adjuvant 4 tremelimumab 3 osimertinib 3 cediranib 3 Watchful Waiting 3 Radiotherapy, Conformal 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03445000 2025-04-08

ALERT-lung

ETOP IBCSG Partners Foundation

Phase 2 Terminated

14 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡